Anugerah 88

92.83

-0.58

|(-0.62%)

52W H: 122.252W L: 74.5Beta: 2.14

About Rhythm Pharmaceuticals Inc

Industry: Biotechnology
Exchange: NASDAQ NMS - GLOBAL MARKET
Country: US
Website: https://rhythmtx.com/

Frequently Asked Questions

What is the 52-week range for RYTM?

The 52-week high is $122.2 and the 52-week low is $74.5.

What is the P/E ratio for RYTM?

The P/E ratio data is currently unavailable.

What is the dividend yield for RYTM?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -80.48%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -85.59%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 26.45.

Analyst Recommendation Trends

Wall Street analyst consensus for RYTM over the last few months:

2026-09-01

Buy: 12

S.Buy: 8

Hold: 3

Sell: 0

2026-08-01

Buy: 12

S.Buy: 8

Hold: 2

Sell: 0

2026-07-01

Buy: 12

S.Buy: 8

Hold: 2

Sell: 0

2026-06-01

Buy: 12

S.Buy: 8

Hold: 2

Sell: 0

Latest RYTM News

Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity

-- First targeted therapy approved in Canada for patients four years and older living with acquired hypothalamic obesity (HO) --BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that Health Canada has approved IMCIVREE® (setmelanotide) for the additional indication of weight management in adult and pediat

Yahoo9/22/2026

Rhythm Pharmaceuticals Receives Health Canada Approval Of IMCIVREE For Additional Indication Of Weight Management In Adult And Pediatric Patients 4 Years Of Age And Older With Acquired Hypothalamic Obesity

IMCIVREE was first approved by Health Canada in 2023 for weight management in adult and pediatric patients 6 years of age and older with obesity due to Bardet-Biedl syndrome (BBS), or genetically confirmed biallelic

Benzinga9/22/2026

Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains?

Ultragenyx (RARE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Yahoo9/18/2026

Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Rhythm Pharmaceuticals, Inc. (RYTM) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 1:50 PM EDTCompany ParticipantsDavid Meeker -...

SeekingAlpha9/15/2026

10 Health Care Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will

Benzinga9/11/2026

Billionaire Stanley Druckenmiller’s 2 New Healthcare Stock Picks

Stanley Druckenmiller’s Duquesne Family Office recently filed its 13F for the second quarter. The firm opened new stakes in more than 40 stocks. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) and Definium Therapeutics, Inc. (NASDAQ:DFTX) are the notable ones in the healthcare space. Duquesne bought 203,618 shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) worth $22.6 million. The fund also […]

Yahoo9/11/2026

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

-- Real-world data showed reductions in BMI with up to 18 months of setmelanotide therapy in 30 paediatric patients with acquired hypothalamic obesity (HO) in France – -- Phase 3 analyses demonstrated improvements across multiple cardiometabolic risk indices with setmelanotide in acquired HO -- BOSTON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare n

Yahoo9/10/2026

Related Stocks (Peers)

Companies operating in similar sectors to RYTM:

IMVT IOVA GRAL RYTM CGON KOD SRRK ORKA MIRM COGT 950160.KQ

Recent Insider Transactions

Date	Name	Shares Changed	Price	Value
2026-09-14	Meeker David P	-50,000	-	-
2026-09-14	Meeker David P	-2,300	$105.19	$241,937
2026-09-14	Meeker David P	-1,817	$104.5487	$189,965
2026-09-14	Meeker David P	-8,698	$103.43	$899,634
2026-09-14	Meeker David P	-30,746	$102.347	$3,146,761
2026-09-14	Meeker David P	-6,439	$101.7464	$655,145
2026-09-14	Meeker David P	+50,000	$6.05	$302,500
2026-08-31	Smith Hunter C	-57,187	-	-
2026-08-31	Smith Hunter C	-28,188	$106.2029	$2,993,647
2026-08-31	Smith Hunter C	-11,514	$105.3702	$1,213,232
2026-08-31	Smith Hunter C	-23,072	$104.5871	$2,413,034
2026-08-31	Smith Hunter C	+57,187	$25.79	$1,474,853
2026-08-17	Joshi Manher	+25,000	-	-
2026-08-17	Joshi Manher	+50,000	-	-
2026-08-13	Shulman Joseph	-2,024	-	-
2026-08-13	Shulman Joseph	-5,079	$119.75	$608,210
2026-08-13	Shulman Joseph	+2,024	$6.8	$13,763
2026-08-13	Garfield Alastair	-800	$119.1688	$95,335
2026-08-13	Garfield Alastair	-3,400	$118.2843	$402,167
2026-08-13	Garfield Alastair	-1,556	$117.0759	$182,170
2026-08-13	Garfield Alastair	-2,007	$116.1093	$233,031
2026-08-13	Lee Jennifer Kayden	-21,601	-	-
2026-08-13	Lee Jennifer Kayden	-35,000	-	-
2026-08-13	Lee Jennifer Kayden	-75,834	$117.3818	$8,901,531
2026-08-13	Lee Jennifer Kayden	+21,601	$6.8	$146,887
2026-08-13	Lee Jennifer Kayden	+35,000	$24.29	$850,150
2026-08-12	Mazabraud Yann	-46,625	-	-
2026-08-12	Mazabraud Yann	-17,319	$117.4686	$2,034,439
2026-08-12	Mazabraud Yann	-18,208	$116.4941	$2,121,125
2026-08-12	Mazabraud Yann	-14,568	$115.427	$1,681,541
2026-08-12	Mazabraud Yann	-3,605	$114.6955	$413,477
2026-08-12	Mazabraud Yann	-1,000	$112.856	$112,856
2026-08-12	Mazabraud Yann	-2,300	$111.7992	$257,138
2026-08-12	Mazabraud Yann	+46,625	$6.8	$317,050
2026-07-01	Garfield Alastair	-4,445	-	-
2026-07-01	Garfield Alastair	-2,150	$110.41	$237,382
2026-07-01	Garfield Alastair	+4,445	-	-
2026-06-24	TETRAULT LYNN A.	+2,324	-	-
2026-06-24	TETRAULT LYNN A.	+3,691	-	-
2026-06-24	Arbuckle Stuart A	+2,324	-	-
2026-06-24	Arbuckle Stuart A	+3,691	-	-
2026-06-24	JEAN CHRISTOPHE	+2,324	-	-
2026-06-24	JEAN CHRISTOPHE	+3,691	-	-
2026-06-24	GOOD JENNIFER L	+2,324	-	-
2026-06-24	GOOD JENNIFER L	+3,691	-	-
2026-06-24	MCGIRR DAVID W J	+2,324	-	-
2026-06-24	MCGIRR DAVID W J	+3,691	-	-
2026-06-23	TETRAULT LYNN A.	-4,712	-	-
2026-06-23	TETRAULT LYNN A.	+4,712	-	-
2026-06-23	Arbuckle Stuart A	-4,712	-	-
2026-06-23	Arbuckle Stuart A	+4,712	-	-
2026-06-23	JEAN CHRISTOPHE	-4,712	-	-
2026-06-23	JEAN CHRISTOPHE	+4,712	-	-
2026-06-23	GOOD JENNIFER L	-4,712	-	-
2026-06-23	GOOD JENNIFER L	+4,712	-	-
2026-06-23	MCGIRR DAVID W J	-4,712	-	-
2026-06-23	MCGIRR DAVID W J	+4,712	-	-
2026-06-22	TETRAULT LYNN A.	-37,000	-	-
2026-06-22	TETRAULT LYNN A.	-37,000	$100.3215	$3,711,896
2026-06-22	TETRAULT LYNN A.	+37,000	$28.27	$1,045,990
2026-05-18	Smith Hunter C	-3,000	-	-
2026-05-18	Smith Hunter C	+3,000	$17.87	$53,610
2026-05-15	German Christopher Paul	-1,406	-	-
2026-05-15	German Christopher Paul	-1,349	-	-
2026-05-15	German Christopher Paul	-1,687	-	-
2026-05-15	German Christopher Paul	-4,643	$92.21	$428,131
2026-05-15	German Christopher Paul	+1,406	$17.97	$25,266
2026-05-15	German Christopher Paul	+1,349	$49.23	$66,411
2026-05-15	German Christopher Paul	+1,687	$56.69	$95,636
2026-04-01	Mazabraud Yann	-2,500	-	-
2026-04-01	Mazabraud Yann	-10,375	-	-
2026-04-01	Mazabraud Yann	+12,875	-	-
2026-04-01	Popovits Kimberly J	+10,257	-	-
2026-04-01	Popovits Kimberly J	+6,808	-	-
2026-03-12	Mathers Edward T	+4,199	-	-
2026-03-04	German Christopher Paul	-1,500	-	-
2026-03-04	German Christopher Paul	-5,614	$89.56	$502,790
2026-03-04	German Christopher Paul	+1,500	$17.97	$26,955
2026-03-02	Mazabraud Yann	+35,000	-	-
2026-03-02	Mathers Edward T	+4,198	-	-
2026-03-02	Smith Hunter C	-6,099	-	-
2026-03-02	Smith Hunter C	+6,099	$6.8	$41,473
2026-03-01	German Christopher Paul	-1,162	-	-
2026-03-01	German Christopher Paul	-342	$94.94	$32,469
2026-03-01	German Christopher Paul	+1,162	-	-
2026-02-19	Smith Hunter C	-585	$103.2828	$60,420
2026-02-19	Smith Hunter C	-800	$102.0951	$81,676
2026-02-19	Smith Hunter C	-1,692	$100.9189	$170,755
2026-02-19	Smith Hunter C	-1,308	$100.2698	$131,153
2026-02-17	Smith Hunter C	-200	$103.84	$20,768
2026-02-17	Smith Hunter C	-1,069	$103.0024	$110,110
2026-02-17	Smith Hunter C	-900	$101.7	$91,530
2026-02-17	Smith Hunter C	-200	$100.52	$20,104
2026-02-17	Smith Hunter C	-1,200	$99.415	$119,298
2026-02-14	Mazabraud Yann	-10,000	-	-
2026-02-14	Mazabraud Yann	+10,000	-	-
2026-02-12	Smith Hunter C	-100	$100.1	$10,010
2026-02-12	Smith Hunter C	-800	$98.9906	$79,192
2026-02-12	Smith Hunter C	-400	$97.6713	$39,069
2026-02-12	Smith Hunter C	-292	$96.2627	$28,109
2026-02-11	Shulman Joseph	+22,500	-	-
2026-02-11	Shulman Joseph	+15,000	-	-
2026-02-11	Mazabraud Yann	+23,350	-	-
2026-02-11	Lee Jennifer Kayden	+32,500	-	-
2026-02-11	Lee Jennifer Kayden	+21,650	-	-
2026-02-11	Garfield Alastair	+25,000	-	-
2026-02-11	Garfield Alastair	+16,650	-	-
2026-02-11	Cramer Pamela J.	+17,500	-	-
2026-02-11	Cramer Pamela J.	+11,650	-	-
2026-02-11	Smith Hunter C	+37,500	-	-
2026-02-11	Smith Hunter C	+25,000	-	-
2026-02-11	Smith Hunter C	-100	$100.8527	$10,085
2026-02-11	Smith Hunter C	-400	$99.4368	$39,775
2026-02-11	Smith Hunter C	-2,266	$98.37	$222,906
2026-02-11	Meeker David P	+107,850	-	-
2026-02-11	Meeker David P	+71,900	-	-
2026-02-11	German Christopher Paul	+5,215	-	-
2026-02-10	Smith Hunter C	-100	$104.76	$10,476
2026-02-10	Smith Hunter C	-700	$103.6767	$72,574
2026-02-10	Smith Hunter C	-1,913	$102.6554	$196,380
2026-02-05	Smith Hunter C	-3,381	$106.063	$358,599
2026-02-04	Smith Hunter C	-747	$107.6654	$80,426
2026-02-04	Smith Hunter C	-1,000	$106.604	$106,604
2026-02-04	Smith Hunter C	-1,500	$104.7434	$157,115
2026-02-01	Mazabraud Yann	-5,500	-	-
2026-02-01	Mazabraud Yann	+5,500	-	-
2026-02-01	Shulman Joseph	-6,250	-	-
2026-02-01	Shulman Joseph	-4,125	-	-
2026-02-01	Shulman Joseph	-3,937	-	-
2026-02-01	Shulman Joseph	-2,656	-	-
2026-02-01	Shulman Joseph	-6,507	$108.99	$709,198
2026-02-01	Shulman Joseph	+16,968	-	-
2026-02-01	Lee Jennifer Kayden	-9,163	-	-
2026-02-01	Lee Jennifer Kayden	-5,500	-	-
2026-02-01	Lee Jennifer Kayden	-4,512	-	-
2026-02-01	Lee Jennifer Kayden	-3,437	-	-
2026-02-01	Lee Jennifer Kayden	-9,237	$108.99	$1,006,741
2026-02-01	Lee Jennifer Kayden	+22,612	-	-
2026-02-01	Garfield Alastair	-6,663	-	-
2026-02-01	Garfield Alastair	-2,026	$108.99	$220,814
2026-02-01	Garfield Alastair	+6,663	-	-
2026-02-01	Cramer Pamela J.	-5,000	-	-
2026-02-01	Cramer Pamela J.	-3,300	-	-
2026-02-01	Cramer Pamela J.	-2,650	-	-
2026-02-01	Cramer Pamela J.	-2,343	-	-
2026-02-01	Cramer Pamela J.	-4,731	$108.99	$515,632
2026-02-01	Cramer Pamela J.	+13,293	-	-
2026-02-01	Smith Hunter C	-10,413	-	-
2026-02-01	Smith Hunter C	-6,600	-	-
2026-02-01	Smith Hunter C	-4,925	-	-
2026-02-01	Smith Hunter C	-4,062	-	-
2026-02-01	Smith Hunter C	-10,750	$108.99	$1,171,643
2026-02-01	Smith Hunter C	+26,000	-	-
2026-02-01	Meeker David P	-33,338	-	-
2026-02-01	Meeker David P	-21,250	-	-
2026-02-01	Meeker David P	-14,125	-	-
2026-02-01	Meeker David P	-31,522	$108.99	$3,435,583
2026-02-01	Meeker David P	+68,713	-	-
2026-02-01	German Christopher Paul	-1,807	-	-
2026-02-01	German Christopher Paul	-1,806	-	-
2026-02-01	German Christopher Paul	-1,138	$108.99	$124,031
2026-02-01	German Christopher Paul	+3,613	-	-
2025-12-11	Cramer Pamela J.	-3,350	-	-
2025-12-11	Cramer Pamela J.	-3,350	$111	$371,850
2025-12-11	Cramer Pamela J.	+3,350	$27.35	$91,623
2025-11-20	Cramer Pamela J.	-3,350	-	-
2025-11-20	Cramer Pamela J.	-3,350	$105	$351,750
2025-11-20	Cramer Pamela J.	+3,350	$27.35	$91,623
2025-11-10	Cramer Pamela J.	-3,515	-	-
2025-11-10	Cramer Pamela J.	-3,515	$100	$351,500
2025-11-10	Cramer Pamela J.	+3,515	$6.8	$23,902
2025-11-07	Cramer Pamela J.	-10,546	-	-
2025-11-07	Cramer Pamela J.	-8,805	-	-
2025-11-07	Cramer Pamela J.	-19,351	$98.8231	$1,912,326
2025-11-07	Cramer Pamela J.	+10,546	$6.8	$71,713
2025-11-07	Cramer Pamela J.	+8,805	$19.02	$167,471
2025-10-30	Shulman Joseph	-9,748	-	-
2025-10-30	Shulman Joseph	-9,748	$115.2439	$1,123,398
2025-10-30	Shulman Joseph	+9,748	$30.66	$298,874
2025-10-28	Shulman Joseph	-721	-	-
2025-10-28	Shulman Joseph	-2,094	-	-
2025-10-28	Shulman Joseph	-2,815	$115.0089	$323,750
2025-10-28	Shulman Joseph	+721	$30.66	$22,106
2025-10-28	Shulman Joseph	+2,094	$27.35	$57,271
2025-10-16	Shulman Joseph	-12,344	-	-
2025-10-16	Shulman Joseph	-2,093	-	-
2025-10-16	Shulman Joseph	-3,412	$112.81	$384,908
2025-10-16	Shulman Joseph	-8,332	$112.0554	$933,646
2025-10-16	Shulman Joseph	-2,693	$110.9482	$298,784
2025-10-16	Shulman Joseph	+12,344	$30.66	$378,467
2025-10-16	Shulman Joseph	+2,093	$27.35	$57,244